rs137854570
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.2138C>G(p.Ser713*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:2
This variant disrupts a region of the APC protein in which other variant(s) (p.Tyr2645Lysfs*14) have been determined to be pathogenic (PMID: 1316610, 8381579, 9824584, 22135120, 27081525; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This sequence change creates a premature translational stop signal (p.Ser713*) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2131 amino acid(s) of the APC protein. This variant is not present in population databases (ExAC no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of APC-related conditions (PMID: 1651563, 30897307). ClinVar contains an entry for this variant (Variation ID: 800). For these reasons, this variant has been classified as Pathogenic. This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Gardner syndrome Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.S713* pathogenic mutation (also known as c.2138C>G), located in coding exon 15 of the APC gene, results from a C to G substitution at nucleotide position 2138. This changes the amino acid from a serine to a stop codon within coding exon 15. This alteration has been described in numerous individuals with adenomatous polyposis in the literature (Giarola M et al. Hum. Mutat. 1999; 13:116-23, Miyoshi Y et al. Proc. Natl. Acad. Sci. U.S.A. 1992; 89:4452-6, Nishisho I et al. Science 1991; 253:665-9). One such individual also had mandibular osteomas, consistent with the Gardner syndrome phenotype included in the FAP spectrum (Nishisho I et al. Science 1991; 253:665-9). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at